Non-Antibody Scaffolds as Alternative Therapeutic Agents

作者: Markus Fiedler , Arne Skerra

DOI: 10.1002/9783527682423.CH17

关键词:

摘要:

参考文章(176)
Mi-Ae Lyu, Yu (Joshua) Cao, Khalid A. Mohamedali, Michael G. Rosenblum, Cell-targeting fusion constructs containing recombinant gelonin. Methods in Enzymology. ,vol. 502, pp. 167- 214 ,(2012) , 10.1016/B978-0-12-416039-2.00008-2
Michaela Gebauer, Arne Skerra, Anticalins small engineered binding proteins based on the lipocalin scaffold. Methods in Enzymology. ,vol. 503, pp. 157- 188 ,(2012) , 10.1016/B978-0-12-396962-0.00007-0
Caroline Barelle, Davinder S. Gill, Keith Charlton, Shark Novel Antigen Receptors—The Next Generation of Biologic Therapeutics? Pharmaceutical Biotechnology. ,vol. 655, pp. 49- 62 ,(2009) , 10.1007/978-1-4419-1132-2_6
K. Dane Wittrup, Greg M. Thurber, Michael M. Schmidt, John J. Rhoden, Practical theoretic guidance for the design of tumor-targeting agents. Methods in Enzymology. ,vol. 503, pp. 255- 268 ,(2012) , 10.1016/B978-0-12-396962-0.00010-0
Robert Huber, Monika Schneider, Irmgard Mayr, Rudi Müller, Rainer Deutzmann, Franz Suter, Herbert Zuber, Heinz Falk, Hartmut Kayser, Molecular structure of the bilin binding protein (BBP) from Pieris brassicae after refinement at 2.0 Å resolution Journal of Molecular Biology. ,vol. 198, pp. 499- 513 ,(1987) , 10.1016/0022-2836(87)90296-8
Paul Carter, Improving the efficacy of antibody-based cancer therapies Nature Reviews Cancer. ,vol. 1, pp. 118- 129 ,(2001) , 10.1038/35101072
Daniel Legendre, Patrice Soumillion, Jacques Fastrez, Engineering a regulatable enzyme for homogeneous immunoassays Nature Biotechnology. ,vol. 17, pp. 67- 72 ,(1999) , 10.1038/5243